Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Jan 13, 2022 9:21am
122 Views
Post# 34312021

RE:RE:RE:RE:RE:Meetings with large shareholders

RE:RE:RE:RE:RE:Meetings with large shareholdersThis is different than what I thought,,,Unless those retail shareholders are really large it seems that lmost  posters here would  probably meet the major shareholder criteria so the agenda of the Meeting  will probably be just a Corporate Presentation with maybe the smile o meter going higher than usual

SPCEO1 wrote: These two shareholders are financial advisors with retail clients in their local area for whom they hold TH. They are inviting those clients to come hear what TH has to say as they have done in the past. They rented a sizable room at a local hotel for the presentation so they can be socially distanced.
palinc2000 wrote:

It never crossed my mind that non public material information would be disclosed during those private meetings but I also know that they are much less formal and the tone much less guarded and attendees might come put of the meeting with a slightly different perspective......
 

I am confused when you write about shareholders having reserved rooms for their clients..... I thought this was a meeting of major shareholders like Soleus and others like you but not of clients 
????

 

SPCEO1 wrote: The meetings basically were confirmed - one of the shareholders had invitations printed up and already has a room reserved at a hotel for his clients. But I imagine the covid factor is still in play. 

I get the impression you think this "private, closed door" meeting would contain non=public info and that is why they wouuld not record it. Having been to them before, I can tell you that is not the case. They would not record it simply because the meeting is being sponsored by the shareholder more than the company. If the shareholder wanted to record it, I imagine THTX would not object. Companies simply do not typically go around sharing inside, priveleged info. Access like this may give a shareholder an opportunity to observe management's attitudes andsuch and draw some inferences from that which may or may not ultimately prove to be accurate, but that is about it. Basically, if the meetings are held, I would expect the new corporate presentation to be released on the day of the first meeting, if not before that, and Paul and Philippe to just give that and answer questions. Most of the people at these meetings are clients of financial advisors who have some knowledge of TH but not typically enough to ask really penetrating questions. It should be a relatively easy presentation for the company if they have good news to share. If not, these folks may be even grumpier than the Grumpy Grader! People have held onto TH for a long time andonly seen it go down int he last few years while it seemed like just about every other stock went  up. Moreover, TH had some exciting developments in NASH and cancer as well as a new CEO appointed during those years and yet it could not capitalize on them in a manner that helped the share price. So, the average shareholder is pretty ticked off, as you might expect. TH has some of the nicest shareholders in existence but everyone's patienceultiately has a limit. 
 

 

palinc2000 wrote: Using Covid to cancell a Meeting in person is not a valid reason based on current  regulations and borders are open      I doubt that a private closed door meeting would be held on zoom which could allow participants to record  the meeting (audio and video) ....I thought the meeetomg was confirmed 

 

 




<< Previous
Bullboard Posts
Next >>